The Scientist

» breast cancer

Most Recent

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Breast Cancer Pioneer Dies

Breast Cancer Pioneer Dies

By | January 3, 2013

Elwood Jensen, whose research inspired new treatments for breast cancer, has passed away at age 92.

0 Comments

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Breast Cancer Screening Saves Lives

Breast Cancer Screening Saves Lives

By | November 2, 2012

An expert panel finds that the benefits of breast cancer screening outweigh risks that the procedure will lead to unnecessary treatments.

1 Comment

image: Cancer-Enhancing Stress

Cancer-Enhancing Stress

By | July 17, 2012

Depression in post-op breast cancer patients can cause tumors to establish in bone.

8 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

image: Trials Overlook Cancer Spread

Trials Overlook Cancer Spread

By | May 30, 2012

One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.

0 Comments

image: The Best of Experimental Biology

The Best of Experimental Biology

By | April 25, 2012

From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.

4 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech